Patent details

Basic Information

Publication number:

EP3733712

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP201809381

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB

French Title of Invention:

RÉGIMES ET PROCÉDÉS DE TRAITEMENT DE LA SCLÉROSE EN PLAQUES À L'AIDE D'OFATUMUMAB

German Title of Invention:

THERAPIEPLÄNE UND VERFAHREN ZUR BEHANDLUNG VON MULTIPLER SKLEROSE MITTELS OFATUMUMAB

SPC Number:

Dates

Filing date:

11/08/2017

Grant date:

24/05/2023

EP Publication Date:

04/11/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/05/2023

EP B1 Publication Date:

24/05/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/08/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/05/2023

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

08/08/2023

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

SAVELIEVA PRAZ, Marina

Address:

Switzerland (CH)

2

Name:

WALLSTRÖM, Erik

Address:

Switzerland (CH)

3

Name:

KAHN, Joseph Michael

Address:

United States (US)

4

Name:

KAKARIEKA WEISSKOPF, Algirdas Jonas

Address:

Switzerland (CH)

Priority

Priority Number:

201662374986 P

Priority Date:

15/08/2016

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28; A61K 39/395; A61P 25/00;

Publication

European Patent Bulletin

1

Issue number:

202321

Publication date:

24/05/2023

Description:

Grant (B1)

2

Issue number:

202324

Publication date:

14/06/2023

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

01/09/2025

Annual Fee Number:

9

Annual Fee Amount:

115 Euro

Expected Payer:

Last Annual Fee Payment Date:

26/07/2024

Last Annual Fee Paid Number:

8

Last Annual Fee Paid Amount:

99 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
08/08/2023	Power Of Attorney	1
09/08/2023	Outgoing Correspondence	1